Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits... Show more
Aehr Test Systems holds a strong position as a leader in wafer-level test and burn-in solutions for advanced semiconductors, particularly SiC, gallium nitride (GaN), photonics, and high-bandwidth memory. Unlike traditional packaged-device testing, Aehr's systems like FOX and Sonoma platforms enable testing at the wafer stage, reducing manufacturing footprint, costs, and time-to-market—a key competitive advantage in high-volume production. This positions the company well amid rising demand for reliable power devices in electric vehicles (EVs) and AI data centers. Partnerships, such as with ISE Labs for high-performance computing qualification, enhance its ecosystem role. Market share in SiC testing remains robust, with expansion into AI-driven silicon photonics signaling diversification beyond EV cyclicality. However, broader competition from larger semi equipment firms poses structural risks if innovation cycles accelerate.
Upcoming fiscal Q4 2026 earnings, expected in July 2026, will provide visibility into FY2027 guidance and AI order momentum following recent record $41 million hyperscaler orders. Strong second-half FY2026 bookings over $92 million underscore potential for revenue acceleration. Product advancements in package-level burn-in for AI ASICs and photonics could yield new contracts, boosting investor confidence. Analyst actions remain pivotal: recent upgrades like William Blair to Outperform contrast with Craig-Hallum's price target cut to $21 (Hold), reflecting divergent views on AI sustainability versus EV weakness. Consensus holds a Buy tilt with average targets near $62-64, but revisions could sway sentiment if bookings sustain. Regulatory shifts in semi supply chains or partnerships may further catalyze upside.
The semiconductor test equipment market is projected to expand from $8.15 billion in 2026 to $14.38 billion by 2034 at a 7.35% CAGR, fueled by complex chip designs in AI and power management. SiC devices, critical for EV inverters and data center power supplies, face explosive growth amid EV adoption and AI infrastructure buildout. Aehr's exposure amplifies sensitivity to these trends: AI hyperscaler capex surges support testing demand, while EV slowdowns have tempered SiC orders. Macro factors like declining interest rates could spur capex in semis and autos, countering inflation pressures on manufacturing. Geopolitical tensions in chip supply chains heighten focus on domestic testing capacity, potentially benefiting U.S.-based Aehr. Technology shifts toward photonics for faster AI interconnects represent additional tailwinds.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it includes searchable prediction categories, historical context, and alert-oriented functionality. Users can leverage these insights to inform trading strategies efficiently. Explore the Trend Prediction Engine today for data-driven trend analysis.
For calendar 2026, aligning with FY2027, Aehr's trajectory hinges on AI data center ramp-ups offsetting any lingering EV softness, with SiC demand rebounding via cost reductions and broader adoption. Market expansion in photonics and high-power memory testing could diversify revenue, supporting margin sustainability through scale. Consensus analyst expectations point to modest growth, with price targets averaging $62 amid Overweight ratings, though variability signals caution on execution. Long-term themes include technology transitions to next-gen burn-in for 2D/3D packaging, competitive threats from scaled rivals, and regulatory pushes for supply chain resilience. Capital allocation toward R&D and capacity will be key, as hyperscaler partnerships solidify positioning in AI infrastructure.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment
A.I.dvisor indicates that over the last year, AEHR has been loosely correlated with ONTO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if AEHR jumps, then ONTO could also see price increases.
| Ticker / NAME | Correlation To AEHR | 1D Price Change % | ||
|---|---|---|---|---|
| AEHR | 100% | +7.43% | ||
| ONTO - AEHR | 59% Loosely correlated | +0.88% | ||
| UCTT - AEHR | 59% Loosely correlated | +2.10% | ||
| AMAT - AEHR | 57% Loosely correlated | +4.35% | ||
| COHU - AEHR | 57% Loosely correlated | +4.87% | ||
| NVMI - AEHR | 56% Loosely correlated | +0.68% | ||
More | ||||
| Ticker / NAME | Correlation To AEHR | 1D Price Change % |
|---|---|---|
| AEHR | 100% | +7.43% |
| Electronic Production Equipment industry (30 stocks) | 66% Loosely correlated | +6.27% |
On June 11, 2026, the Stochastic Oscillator for AEHR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on June 17, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 249 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 43, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AEHR's P/B Ratio (26.110) is slightly higher than the industry average of (12.224). P/E Ratio (19.449) is within average values for comparable stocks, (117.614). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.178). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (76.923) is also within normal values, averaging (185.392).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.